The prototypal newborn test drug to kibosh blood  clotting  since  the  start of anticoagulant in the primeval 1950s has been launched  today.   Pradaxa*  (dabigatran  etexilate)  is the prototypal of a newborn class  of  oral  anticoagulants  - a candid thrombin inhibitor - to be prefabricated available  in  Ireland  by  Boehringer Ingelheim.

Tags: Launch